[HTML][HTML] Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib
A Onn, M Tsuboi - British journal of cancer, 2004 - nature.com
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related
mortality and, until screening detects early disease, treatment for the majority of patients will …
mortality and, until screening detects early disease, treatment for the majority of patients will …
Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib.
A Onn, M Tsuboi, N Thatcher - 2004 - christie.openrepository.com
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related
mortality and, until screening detects early disease, treatment for the majority of patients will …
mortality and, until screening detects early disease, treatment for the majority of patients will …
[HTML][HTML] Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib
A Onn, M Tsuboi, N Thatcher - British Journal of Cancer, 2004 - ncbi.nlm.nih.gov
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related
mortality and, until screening detects early disease, treatment for the majority of patients will …
mortality and, until screening detects early disease, treatment for the majority of patients will …
Treatment of non-small-cell lung cancer: A perspective on the recent advances and the experience with gefitinib
A Onn, M Tsuboi, N Thatcher - British Journal of Cancer, 2004 - research.manchester.ac.uk
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related
mortality and, until screening detects early disease, treatment for the majority of patients will …
mortality and, until screening detects early disease, treatment for the majority of patients will …
Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib.
A Onn, M Tsuboi, N Thatcher - British Journal of Cancer, 2004 - search.ebscohost.com
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related
mortality and, until screening detects early disease, treatment for the majority of patients will …
mortality and, until screening detects early disease, treatment for the majority of patients will …
Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib.
A Onn, M Tsuboi, N Thatcher - British Journal of Cancer, 2004 - europepmc.org
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related
mortality and, until screening detects early disease, treatment for the majority of patients will …
mortality and, until screening detects early disease, treatment for the majority of patients will …
[PDF][PDF] Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib
A Onn, M Tsuboi, N Thatcher - British Journal of Cancer, 2004 - Citeseer
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related
mortality and, until screening detects early disease, treatment for the majority of patients will …
mortality and, until screening detects early disease, treatment for the majority of patients will …
Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib
A Onn, M Tsuboi, N Thatcher - British journal of cancer, 2004 - pubmed.ncbi.nlm.nih.gov
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related
mortality and, until screening detects early disease, treatment for the majority of patients will …
mortality and, until screening detects early disease, treatment for the majority of patients will …
[引用][C] Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib
A Onn, M Tsuboi, N Thatcher - British Journal of Cancer, 2004 - cir.nii.ac.jp
Treatment of non-small-cell lung cancer: a perspective on the recent advances and the
experience with gefitinib | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
experience with gefitinib | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib.
A Onn, M Tsuboi, N Thatcher - British Journal of Cancer, 2004 - europepmc.org
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related
mortality and, until screening detects early disease, treatment for the majority of patients will …
mortality and, until screening detects early disease, treatment for the majority of patients will …